A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

This important study examines the potential role of ARHGAP36 transcriptional regulation by FOXC1 in controlling sonic hedgehog signaling in human neuroblastoma. While there are many solid findings ...

Intellia Therapeutics, Inc. is rated Hold due to uncertainty from dosing pause in its MAGNITUDE program for ATTR. Learn more ...

Intellia Therapeutics has paused dosing in its Phase 3 MAGNITUDE trials after a patient experienced severe liver toxicity, as the company investigates and works with regulators on its CRISPR-based ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

People with Type 1 diabetes lose insulin-producing beta cells due to an autoimmune reaction, forcing lifelong dependence on ...

BANDUNG, itb.ac.id - The PINTAR Diagnostics team from the School of Life Sciences and Technology (SLST), Institut Teknologi ...

Marvel Studios’ “Fantastic Four: First Steps” is expected to land on Disney+ in October or mid-November, following its July 25 theatrical debut. The superhero film is still playing in select theaters, ...

Attempting to cash in on what's likely to be a relatively short-lived mania isn't a good idea for most investors most of the ...